Topic vaccines

Companies vaccines

SIRION BIOTECH GmbH, Germany

SIRION BIOTECH is a technology leader in the field of functional gene analysis and cell models for basic research, drug and compound development. The company serves leading European and Japanese Drug and Biotech companies as a provider of latest technologies for them to advance identification of nov more

Products vaccines

High Performance Crossflow Cassettes Sartocon® ECO with Hydrosart® membrane

Sartocon® ECO is based on Hydrosart® ultrafilter technology that uses cross linked polymer membranes based on hydrophilic cellulose more

News vaccines

• GE Healthcare Life Sciences completes acquisition of Xcellerex, Inc.

  GE Healthcare announced that it has completed the acquisition of Xcellerex, Inc., a supplier of manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of biopharmaceuticals such as more

• Mucosis Announces Positive Proof-Of-Concept Data for Mimopath Platform In Humans

  Mucosis B.V. announced Phase I clinical data providing proof-of-concept that Mimopath®-based mucosal vaccines are safe and well tolerated as well as able to produce balanced immune responses in both circulating blood and the respiratory tract.Mucosis, in conjunction with the Centre for Human Drug Re more

• H1N1 discovery paves way for universal flu vaccine: UBC research

  University of British Columbia researchers have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations. Led by Prof. John Schrader, Canada Research Chair in Immunology and director of UBC's Biomedical Research Centre, the research team found that more

Publications vaccines

• Construction of stable producer cells to make high‐titer lentiviral vectors for dendritic cell‐based vaccination

  Abstract Lentiviral vectors (LVs) enveloped with an engineered Sindbis virus glycoprotein can specifically bind to dendritic cells (DCs) through the surface receptor DC‐SIGN and induce antigen expression, thus providing an efficient method for delivering DC‐directed vaccines. In this study, we co more

• Vaccine process technology

  Abstract The evolution of vaccines (e.g., live attenuated, recombinant) and vaccine production methods (e.g., in ovo, cell culture) are intimately tied to each other. As vaccine technology has advanced, the methods to produce the vaccine have advanced and new vaccine opportunities have been creat more

• Comparison of two eukaryotic systems for the expression of VP6 protein of rotavirus specie A: transient gene expression in HEK293-T cells and insect cell-baculovirus system

  The VP6 protein of rotavirus A (RVA) is a target antigen used for diagnostic assays and also for the development of new RVA vaccines. We have compared the expression of VP6 protein in human embryonic kidney (HEK293-T) cells with results obtained using a well-established insect cell-baculovirus syste more

Market studies vaccines

• Vaccines - Senegal

  This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in Senegal. The analysis provides essential market information for decision-makers including:   * Overall market value for vaccines in Senegal * Overall market volume for more

• iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

  iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

• Iran Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: We continue viewing Iran as one of the less attractive regional markets. Imposition of more stringent international sanctions, rampant inflation, and the loss of confidence in the Iranian rial weigh heavily on consumption and investment patterns, and also on government revenues and the aut more

Websites vaccines